MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis

Chromosomal translocations that involve MYC, characteristic of Burkitt lymphoma, are rare in chronic lymphocytic leukaemia (CLL). We report the clinical, morphological, immunophenotypic, cytogenetic and molecular genetic features of eight CLL cases with MYC rearrangement. The patients, five men and three women (median age, 71 years) had bone marrow involvement and an absolute peripheral blood lymphocytosis; five had lymphadenopathy; seven had splenomegaly. Prolymphocytes were increased (≥10%) in all cases. Six cases were classified as CLL with increased prolymphocytes (CLL/PL; prolymphocytes 10–55%), and two were classified as CLL in prolymphocytic transformation (CLL/PT; prolymphocytes >55%). All cases co‐expressed CD5, CD19, and CD23; five of eight expressed ZAP‐70. Of seven cases tested, four had mutated and three had unmutated IGHV genes. Conventional cytogenetic studies demonstrated t(8;14)(q24·1;q32) in five cases, t(8;22)(q24·1;q11) in two cases, and t(2;8)(p12;q24·1) in one case. Seven cases contained additional chromosomal abnormalities. All patients received combination chemotherapy. Two developed Epstein–Barr virus (EBV)‐associated diffuse large B‐cell lymphomas (DLBCL) that were clonally unrelated to the CLL. At follow‐up, two patients are alive, four died of underlying disease, one died of EBV‐associated DLBCL, and one died of an unrelated cancer. In summary, MYC rearrangement, which occurs rarely in CLL patients, is associated with increased prolymphocytes, complex cytogenetic abnormalities, and a poor prognosis.

[1]  D. Givol,et al.  A search for bcl1, bcl2, and c-myc oncogene rearrangements in chronic lymphocytic leukemia. , 1989, Leukemia.

[2]  M. Raffeld,et al.  Oncogene rearrangements in chronic B-cell leukemia. , 1991, Blood.

[3]  D. Arthur,et al.  Transformation of chronic lymphocytic leukemia to small non-cleaved cell lymphoma: a cytogenetic, immunological, and molecular study. , 1991, Leukemia.

[4]  R. Gascoyne,et al.  Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies. , 1993, Leukemia & lymphoma.

[5]  F. Herrmann,et al.  Burkitt-like mutations in the c-myc gene locus in prolymphocytic leukemia. , 1994, Leukemia.

[6]  D. Catovsky,et al.  The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. , 1994, Leukemia.

[7]  A. Al-Katib,et al.  Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia. , 1996, Cancer genetics and cytogenetics.

[8]  H. Yamasaki,et al.  Burkitt's type acute lymphoblastic transformation associated with t(8;14) in a case of B cell chronic lymphocytic leukemia. , 1997, Leukemia.

[9]  D. Catovsky,et al.  Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). , 1997, American journal of clinical pathology.

[10]  M. Keating,et al.  Chronic lymphocytic leukemia in (Richter's) transformation. , 1998, Seminars in oncology.

[11]  L. Rassenti,et al.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. , 1998, The Journal of clinical investigation.

[12]  D. Catovsky,et al.  B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene , 1999, Leukemia.

[13]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[14]  A Benner,et al.  Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.

[15]  C. Dang,et al.  Translocations involving c-myc and c-myc function , 2001, Oncogene.

[16]  M. Keating,et al.  Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia. , 2001, American journal of clinical pathology.

[17]  J. Manning,et al.  Epstein–Barr Virus-Positive B-Cell Lymphoproliferative Disorders Arising in Immunodeficient Patients Previously Treated With Fludarabine for Low-Grade B-Cell Neoplasms , 2002, The American journal of surgical pathology.

[18]  David Botstein,et al.  Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Sanger,et al.  Mantle Cell Lymphoma with 8q24 Chromosomal Abnormalities: a Report of 5 Cases with Blastoid Features , 2002, Modern Pathology.

[20]  W. Sanger,et al.  Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. , 2003, Archives of pathology & laboratory medicine.

[21]  Emili Montserrat,et al.  ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.

[22]  D. V. Van Dyke,et al.  Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia. , 2004, Cancer genetics and cytogenetics.

[23]  Arthur Weiss,et al.  ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.

[24]  G. Rassidakis,et al.  Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma , 2004, Modern Pathology.

[25]  Ida Retter,et al.  VBASE2, an integrative V gene database , 2004, Nucleic Acids Res..

[26]  T. Shanafelt,et al.  Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia , 2005, British journal of haematology.

[27]  Axel Benner,et al.  Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  L. Medeiros,et al.  Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis , 2006, Modern Pathology.

[29]  K. Reddy,et al.  Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature. , 2006, Cancer genetics and cytogenetics.

[30]  L. Medeiros,et al.  Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma , 2007, Modern Pathology.

[31]  R. Zini,et al.  High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis , 2007, Haematologica.

[32]  L. Peterson,et al.  Chronic lymphocytic leukemia FISH panel: impact on diagnosis. , 2007, American journal of clinical pathology.